Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Friday, April 19, 2024 | Back issues
Courthouse News Service Courthouse News Service

Drug Patent

Drug Patent

MINNEAPOLIS — The blockbuster Hepatitis C drug Harvoni, which sells for $1,100 a pill, violates the sofobuvir patent, as do two other Gilead drugs, the University of Minnesota claims in a federal complaint.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...